ストックスクリーナーアプリを入手
3.68
6.84%
-0.27
アフターアワーズ：
3.75
0.07
+1.90%
前日終値:
$3.95
開ける：
$3.95
24時間の取引高:
1.36M
Relative Volume:
2.96
時価総額：
$83.40M
収益：
$52.55M
当期純損益:
$-23.69M
株価収益率:
-3.9149
EPS:
-0.94
ネットキャッシュフロー:
$-15.29M
1週間 パフォーマンス:
-20.00%
1か月 パフォーマンス:
-38.77%
6か月 パフォーマンス:
-57.36%
1年 パフォーマンス:
-10.24%
1日の値動き範囲:
$3.525
$3.95
1週間の範囲:
$3.525
$4.69
52週間の値動き範囲:
$2.77
$12.23
Exagen Inc Stock (XGN) Company Profile
XGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
3.68 | 89.52M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
578.61 | 222.48B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
218.89 | 155.25B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
670.46 | 54.04B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
230.15 | 40.13B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
133.85 | 37.78B | 6.95B | 1.30B | 1.15B | 4.5696 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-11 | 開始されました | B. Riley Securities | Buy |
| 2025-07-30 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | 開始されました | Craig Hallum | Buy |
| 2022-08-05 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-04-15 | 開始されました | Canaccord Genuity | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-06-02 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 開始されました | Cowen | Outperform |
| 2019-10-14 | 開始されました | William Blair | Outperform |
すべてを表示
Exagen Inc (XGN) 最新ニュース
B. Riley Cuts Price Target on Exagen to $8 From $18, Keeps Buy Rating - marketscreener.com
XGN: B. Riley Securities Lowers Price Target, Maintains Buy Rati - GuruFocus
Exagen's (XGN) "Buy" Rating Reaffirmed at B. Riley - MarketBeat
Is Exagen Inc. impacted by rising rates2025 Volume Leaders & High Accuracy Investment Signals - mfd.ru
What are Exagen Inc.’s recent SEC filings showingWeekly Gains Summary & Weekly Return Optimization Plans - mfd.ru
How The Exagen (XGN) Story Is Shifting With A New Analyst Price Target - Yahoo Finance
Volume Recap: Does Crescent Capital BDC Inc stock reflect fundamentals2025 Earnings Impact & Daily Profit Focused Stock Screening - baoquankhu1.vn
Benign Growth For Exagen Inc. (NASDAQ:XGN) Underpins Stock's 26% Plummet - 富途牛牛
Trend Report: Will Exagen Inc benefit from current market trendsTrade Entry Summary & Daily Chart Pattern Signals - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Sees Large Growth in Short Interest - MarketBeat
Investors Don't See Light At End Of Exagen Inc.'s (NASDAQ:XGN) Tunnel And Push Stock Down 28% - Sahm
Selling Exagen Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Sahm
Tech Rally: Is Exagen Inc. benefiting from innovation trends2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
ETF Watch: How Exagen Inc stock benefits from global expansionJuly 2025 Technicals & Community Consensus Stock Picks - Bộ Nội Vụ
Published on: 2026-01-13 10:11:31 - ulpravda.ru
Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail
How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story - Yahoo Finance
Exagen Announces Record 2025 Revenue and Strong Cash Position - TipRanks
Canaccord Genuity maintains Buy rating on Exagen stock amid ASP challenges - Investing.com Canada
California-based Exagen preliminary revenue up 19% in FY25 - Medical Buyer
Exagen (XGN) Reports Strong Annual Growth and Strategic Advances - GuruFocus
Exagen Inc. Reports Preliminary Financial Results for Q4 and Full Year 2025, Highlighting Record Revenue Growth - Quiver Quantitative
Exagen Inc. Announces Select Preliminary 2025 Financial Results - Bluefield Daily Telegraph
Autoimmune testing firm Exagen ends 2025 with record sales and more cash - Stock Titan
Why Exagen Inc. stock could rally in 2025Forecast Cut & Real-Time Sentiment Analysis - Улправда
T Inc Class stock compares with tech leaders2025 Top Gainers & Safe Capital Allocation Plans - ulpravda.ru
Aug Macro: What margin trends mean for Exagen Inc. stockMarket Growth Review & Long-Term Safe Return Strategies - ulpravda.ru
Is Exagen Inc. stock positioned well for digital economyMarket Trend Summary & High Accuracy Swing Entry Alerts - ulpravda.ru
What margin trends mean for Exagen Inc. stockEarnings Growth Summary & Weekly Market Pulse Alerts - ulpravda.ru
What makes Exagen Inc. stock attractive to growth funds2025 Market Overview & Stock Portfolio Risk Management - ulpravda.ru
Revenue Check: Can Huron Consulting Group Inc. stock deliver surprise earnings beat2025 Macro Impact & AI Forecast Swing Trade Picks - ulpravda.ru
2026 world cup usa squad group stage veteran players set piece strategy knockout prediction analysis - ulpravda.ru
ulpravda ru > 2026> Will LIMN stock beat EPS estimatesQuarterly Trade Summary & High Conviction Buy Zone Picks - ulpravda.ru
Will Exagen Inc. stock outperform Dow Jones indexJuly 2025 Catalysts & Long-Term Safe Return Strategies - Улправда
Will Exagen Inc. (E08A) stock split increase liquidityEarnings Risk Report & Stepwise Trade Signal Implementation - ulpravda.ru
How ImmunityBio Inc. stock trades before earningsJuly 2025 Sector Moves & Real-Time Market Trend Scan - ulpravda.ru
Can Exagen Inc. (E08A) stock reach $200 price targetWeekly Gains Report & Community Consensus Picks - Улправда
Is MIMI stock a smart buy before Fed meetingWeekly Trade Summary & Low Risk High Reward Ideas - ulpravda.ru
ulpravda ru > 2026> Is BPYPO stock dividend yield sustainableMarket Risk Analysis & Fast Entry High Yield Tips - ulpravda.ru
Will Exagen Inc. (E08A) stock rise with strong economyMarket Risk Analysis & Daily Risk Controlled Trade Plans - ulpravda.ru
What momentum indicators show for Exagen Inc. stock2025 Big Picture & Weekly High Return Stock Opportunities - ulpravda.ru
Will Exagen Inc. stock benefit from AI adoption2025 Volatility Report & Verified Short-Term Plans - Улправда
How Exagen Inc. stock reacts to job market dataTrade Execution Strategies & Free Rapid Portfolio Appreciation - Улправда
Why Exagen Inc stock could rally in 2025Market Risk Analysis & Real-Time Price Movement Reports - Bộ Nội Vụ
Free cash flow per share of Exagen, Inc. – SWB:E08A - TradingView — Track All Markets
Exagen Inc E08A Stock Analysis and ForecastTrendline Breakouts & Compound Your Gains With Quality Stocks - earlytimes.in
XGN Stock Price, Forecast & Analysis | EXAGEN INC (NASDAQ:XGN) - Chartmill
American Bio Medica (OTCMKTS:ABMC) versus Exagen (NASDAQ:XGN) Head-To-Head Comparison - Defense World
Will Exagen Inc. stock see PE expansionFibonacci Extensions & Build Wealth With Strategy - bollywoodhelpline.com
Will Exagen Inc. stock benefit from automationDividend Yield Trends & Technical + Fundamental = Smarter Investing - bollywoodhelpline.com
Exagen Inc (XGN) 財務データ
収益
当期純利益
現金流量
EPS
1.19%
0.63%
大文字化:
|
ボリューム (24 時間):